Additional news and analysis, with emphasis on investment opportunities, and including an interview late yesterday (Aug. 12) with Steve Lombardi, President of Helicos BioSciences, was published this ...

Helicos BioSciences has announced that it has received a $2 Million grant from the National Human Genome Research Institute (NHGRI) as part of the Institute’s "Revolutionary Genome Sequencing ...

Helicos BioSciences Corp., a small publicly traded biotech company in Cambridge, may be able to turn a series of fortunate events into a Cinderella story. Helicos (Nasdaq: HLCS) has been riding a wave ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Helicos BioSciences Corporation (NASDAQ: HLCS) announced today that, as part of the Company's previously disclosed efforts to consider alternatives to its existing ...

Helicos Biosciences (www.helicosbio.com) miniaturized the sequencing reaction to the level of individual DNA molecules. In its system each DNA molecule from a sample occupies a distinct position in a ...

Cambridge biotech Helicos BioSciences Corp., which has struggled financially with its genome sequencing device sales business, has decided to launch a diagnostics business designed to leverage the ...

Life scientists are striving to use the information emerging or obtained from the Human Genome Project to gain insight into basic biological processes and to improve human health and disease treatment ...

While giving a tour of Helicos BioSciences' laboratories in Cambridge, Mass., Bill Efcavitch pauses and pats a refrigerator-size 3700 DNA sequencer. The sequencer was made by Applied Biosystems, where ...

Helicos BioSciences, a Cambridge, Mass., maker of high-speed genome-sequencing equipment, raised $48.6 million in an IPO, well under the $81 million it had hoped to raise. My earlier item on the ...